PositiveID Corp. (PSID) Submits FDA 510(k) Application for Mobile Diabetes Health System
PositiveID Corp. develops unique medical devices and biological detection systems. The company's primary focus is on diabetes management, rapid clinical diagnostic testing and airborne bio-threat detection. The company announced today that it has submitted its 510(k) pre-market notification application for its iglucose mobile health system for diabetes management to the US Food and Drug Administration. Positive ID's iglucose is a wireless communication system that facilitates diabetes management by automatically creating electronic logs and journals of blood glucose readings to help ensure patient compliance and data accuracy. PositiveID's iglucose automatically shares this information with family members, caregivers and, most importantly, healthcare…